Загрузка...
Strategies to Obtain Encapsulation and Controlled Release of Pentamidine in Mesoporous Silica Nanoparticles
Pentamidine (PTM), an antiprotozoal agent used in clinics as pentamidine isethionate salt (PTM-S), recently showed high potential also for the treatment of cancer and myotonic dystrophy type I. However, a severe limit to the systemic administration of PTM is represented by its nephrotoxicity, leadin...
Сохранить в:
| Опубликовано в: : | Pharmaceutics |
|---|---|
| Главные авторы: | , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
MDPI
2018
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6320796/ https://ncbi.nlm.nih.gov/pubmed/30347763 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/pharmaceutics10040195 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|